Month: February 2024

Krystal Biotech to Present at Guggenheim 6th Annual Biotechnology Conference

Written by Customer Service on February 1, 2024. Posted in Public Companies.

PITTSBURGH, Feb. 01, 2024 (GLOBE NEWSWIRE) — Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today announced that the Company will participate in the Guggenheim 6th Annual Biotechnology Conference, which takes place in New York on February 7-8. Krish S. Krishnan, Chairman and Chief Executive Officer, will participate in a fireside chat at 10 am ET during the conference and host investor meetings on February 7. A webcast of the presentation will be available here beginning at 10 am ET on Wednesday, February 7 and will be posted on the Investors section of the Company’s website. About Krystal Biotech, Inc.Krystal Biotech, Inc. (NASDAQ: KRYS) is a commercial-stage biotechnology company focused on the discovery, development and commercialization of genetic medicines to treat diseases...

Century Therapeutics to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

Written by Customer Service on February 1, 2024. Posted in Public Companies.

PHILADELPHIA, Feb. 01, 2024 (GLOBE NEWSWIRE) — Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology and autoimmune and inflammatory disease, today announced that members of the management team will participate in a fireside chat at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference on Tuesday, February 8th, 2024 at 2:30 PM ET. A replay of the event will be available on the “Events & Presentations” page in the “Investors” section of the Company’s website at https://investors.centurytx.com/events-and-presentations and will be available for 90 days following the event. About Century Therapeutics Century Therapeutics (NASDAQ: IPSC) is harnessing the power of adult stem cells to develop curative cell therapy...

Stella-Jones Will Hold a Conference Call to Discuss Its Fourth-Quarter Results

Written by Customer Service on February 1, 2024. Posted in Public Companies.

MONTREAL, Feb. 01, 2024 (GLOBE NEWSWIRE) — Stella-Jones Inc. (TSX:SJ). OPEN TO: Investors, analysts and all interested parties DATE: Thursday, February 29, 2024 TIME: 10:00 AM Eastern Standard Time LIVE WEBCAST: https://web.lumiagm.com/440096911 CALL: 1-866-518-4114 THE PRESS RELEASE WILL BE PUBLISHED BEFORE MARKET OPENS THE DAY OF THE CONFERENCE CALL THROUGH GLOBENEWSWIRE. Please log on or dial in 15 minutes before the conference begins. If you are unable to attend at this time, you may access a web recording of the meeting at the following link: https://web.lumiagm.com/440096911. This recording will be available on Thursday, February 29, 2024 as of 1:00 PM EST until 11:59 PM EST on Thursday March 7, 2024. MEDIA WISHING TO QUOTE AN ANALYST SHOULD CONTACT THE ANALYST PERSONALLY FOR...

Acumen Pharmaceuticals Appoints Dr. James Doherty as President and Chief Development Officer

Written by Customer Service on February 1, 2024. Posted in Public Companies.

CHARLOTTESVILLE, Va., Feb. 01, 2024 (GLOBE NEWSWIRE) — Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers for the treatment of Alzheimer’s disease, announced today the appointment of James Doherty, Ph.D., as President and Chief Development Officer, effective February 1, 2024, reporting to Daniel O’Connell, Chief Executive Officer. Dr. Doherty’s responsibilities will include oversight of clinical and non-clinical development, chemistry, manufacturing & controls and regulatory functions. “We are extremely excited to welcome Jim, who brings extensive experience and demonstrated leadership abilities in CNS drug development to Acumen,” Mr. O’Connell said. “I look forward to collaborating with him as we prepare to...

Lantronix to Report Fiscal 2024 Second Quarter Results on Feb. 8, 2024

Written by Customer Service on February 1, 2024. Posted in Public Companies.

IRVINE, Calif., Feb. 01, 2024 (GLOBE NEWSWIRE) — Lantronix Inc. (the “Company”) (NASDAQ: LTRX), a global provider of compute and connectivity IoT solutions that target high-growth industries in Smart Cities, Automotive and Enterprise, today announced it will release financial results from its fiscal 2024 second quarter ended Dec. 31, 2023, after the close of the market on Feb. 8, 2024. Management will host an investor conference call and audio webcast at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) on Feb. 8, 2024. To access the live conference call, investors should dial 1-844-802-2442 (US) or 1-412-317-5135 (international) and indicate that they are participating in the Lantronix fiscal 2024 second-quarter call. The webcast will be available simultaneously via the investor relations section of the Company’s website. Investors...

Applied UV, Inc. to Develop Smart Building Technologies for Larimar City, a New Luxury Development With Six Hotels and 20,000 High-end Residences – Potential Revenues Could Total $250 Million to $300 Million

Written by Customer Service on February 1, 2024. Posted in Public Companies.

Applied UV, Inc.A Rendering of Larimar City & Resort in the Dominican RepublicMax Munn, CEO of AUVI, states: “We estimate that potential revenues from this project could total $250 Million to $300 Million over the next 3 to 6 years.” AUVI subsidiaries (MunnWorks, SteriLumen & LED), in talks with the developer to supply UV disinfection, energy saving smart building control solutions and custom interiors. NEW YORK, NY, Feb. 01, 2024 (GLOBE NEWSWIRE) — via NewMediaWire – Applied UV, Inc. (“Applied UV” or the “Company”) (Nasdaq: AUVI), a leader in smart building technology solutions, announced plans to develop case goods and smart building technologies for Larimar City & Resort, a new multi-use development under construction in the Dominican Republic. The Company expects to deliver prototype case goods, and...

NP Digital Partners with Creative Agency REBL House to Propel Client Success

Written by Customer Service on February 1, 2024. Posted in Mergers And Acquisitions.

Two of Canada’s fastest-growing agencies unite, signaling a bold lead in marketing’s next eraIntroducing REBL by NP DigitalREBL House, the Creative Division of NP DigitalMONTREAL, Feb. 01, 2024 (GLOBE NEWSWIRE) — NP Digital, a global leader in end-to-end performance marketing, has finalized the acquisition of creative and branding agency REBL House. This latest merger bolsters the agency’s in-house creative services and galvanizes the next era of integrated brand and performance marketing for its clients. NP Digital Canada led the acquisition from Quebec, further positioning it for growth in the Quebec market. The merger rounds out its unrivaled approach to end-to-end marketing, adding to its global team of solutions specialists, data analysts, and now a robust team of creative storytellers. REBL House is now the in-house...

Landsbankinn hf.: 2023 financial results of Landsbankinn

Written by Customer Service on February 1, 2024. Posted in Earnings Releases And Operating Results.

Landsbankinn’s after-tax profit in 2023 was ISK 33.2 billion and return on equity was 11.6%. The Board of Directors intends to propose to the Bank’s AGM that the Bank pay a dividend in the amount of ISK 16.6 billion in 2024. The interest margin of domestic households is 2% and remains stable between years. Operating expenses rise in line with a general price increase, but the Bank’s cost-income ratio has never been lower, or 33.7%. Profit in the fourth quarter of 2023 was ISK 10.8 billion and return on equity 14.5%. Rising prices of equities and non-domestic bonds in the Bank’s asset portfolio in 2023 amounted to ISK 15.3 billion. For the fifth year in a row, customers in the banking market are most satisfied with Landsbankinn’s services, according to the Icelandic Performance Satisfaction Index 2023. The Bank’s green bond issuance...

Customer Experience Management (CEM/CXM) Market Size Worth USD 34.47 Billion in 2032 | Emergen Research

Written by Customer Service on February 1, 2024. Posted in Mergers And Acquisitions.

Rising deployment of omnichannel CEM solutions to improve customer experience and rapid adoption of Artificial Intelligence (AI) and Augmented Reality (AR) in industries, such as retail, Information Technology (IT) & telecom, Banking, Financial Services, and Insurance, among others, are major factors driving Customer Experience Management (CEM/CXM) market revenue growth. Vancouver, Feb. 01, 2024 (GLOBE NEWSWIRE) — The global Customer Experience Management (CEM/CXM) market size was USD 10.76 Billion in 2022 and is expected to register a rapid revenue CAGR of 12.3% during the forecast period. Rising deployment of omnichannel CEM solutions to improve customer experience and rapid adoption of Artificial Intelligence (AI) and Augmented Reality (AR) in industries, such as retail, Information Technology (IT) & telecom, Banking,...

Wabash Announces Fourth Quarter and Full Year 2023 Results

Written by Customer Service on February 1, 2024. Posted in Earnings Releases And Operating Results.

Quarterly revenue of $596 million Quarterly operating income of $61.1 million with operating margin of 10.3% Quarterly earnings per diluted share of $1.07 Total backlog steady at $1.9 billion; 12-month backlog up $100 million sequentially to $1.6 billion 2024 Outlook initiated with midpoints of $2.3 billion revenue and diluted earnings per share of $2.25LAFAYETTE, Ind., Feb. 01, 2024 (GLOBE NEWSWIRE) — Wabash (NYSE: WNC), the innovation leader of connected solutions for the transportation, logistics and distribution industries, today reported results for the quarter and full year ended December 31, 2023. For the fourth quarter of 2023, net sales were $596 million. Operating income was $61.1 million, or 10.3% of sales. The Company’s tax rate was lower than usual during the fourth quarter primarily as a result of benefit...

Month: February 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals